Importance of glial activation in neuropathic pain.

Glia plays a crucial role in the maintenance of neuronal homeostasis in the central nervous system. The microglial production of immune factors is believed to play an important role in nociceptive transmission. Pain may now be considered a neuro-immune disorder, since it is known that the activation of immune and immune-like glial cells in the dorsal root ganglia and spinal cord results in the release of both pro- and anti-inflammatory cytokines, as well as algesic and analgesic mediators. In this review we presented an important role of cytokines (IL-1alfa, IL-1beta, IL-2, IL-4, IL-6, IL-10, IL-15, IL-18, TNFalpha, IFNgamma, TGF-beta 1, fractalkine and CCL2); complement components (C1q, C3, C5); metaloproteinases (MMP-2,-9) and many other factors, which become activated on spinal cord and DRG level under neuropathic pain. We discussed the role of the immune system in modulating chronic pain. At present, unsatisfactory treatment of neuropathic pain will seek alternative targets for new drugs and it is possible that anti-inflammatory factors like IL-10, IL-4, IL-1alpha, TGF-beta 1 would fulfill this role. Another novel approach for controlling neuropathic pain can be pharmacological attenuation of glial and immune cell activation. It has been found that propentofylline, pentoxifylline, minocycline and fluorocitrate suppress the development of neuropathic pain. The other way of pain control can be the decrease of pro-nociceptive agents like transcription factor synthesis (NF-kappaB, AP-1); kinase synthesis (MEK, p38MAPK, JNK) and protease activation (cathepsin S, MMP9, MMP2). Additionally, since it is known that the opioid-induced glial activation opposes opioid analgesia, some glial inhibitors, which are safe and clinically well tolerated, are proposed as potential useful ko-analgesic agents for opioid treatment of neuropathic pain. This review pointed to some important mechanisms underlying the development of neuropathic pain, which led to identify some possible new approaches to the treatment of neuropathic pain, based on the more comprehensive knowledge of the interaction between the nervous system and glial and immune cells.

[1]  M. Tidswell,et al.  Toll-like receptor-4 antagonist eritoran tetrasodium for severe sepsis , 2011, Expert review of anti-infective therapy.

[2]  J. Deleo,et al.  A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain , 2008, Brain Research.

[3]  A. Baldwin,et al.  Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.

[4]  L. Duan,et al.  Blocking the glial function suppresses subcutaneous formalin-induced nociceptive behavior in the rat , 2007, Neuroscience Research.

[5]  Annemarie Ledeboer,et al.  Ibudilast (AV-411) , 2007, Expert opinion on investigational drugs.

[6]  P. Sacerdote,et al.  Transient early expression of TNF-α in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy , 2008, Neuroscience Letters.

[7]  E. Benveniste,et al.  Differential regulation of astrocyte TNF-α expression by the cytokines TGF-β, IL-6 and IL-10 , 1995, International Journal of Developmental Neuroscience.

[8]  S. Maier,et al.  Glia as the “bad guys”: Implications for improving clinical pain control and the clinical utility of opioids , 2007, Brain, Behavior, and Immunity.

[9]  Aronson Al.  Pharmacotherapeutics of the newer tetracyclines. , 1980 .

[10]  H. Cho,et al.  Interleukin‐6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK , 2010, European journal of pain.

[11]  S. McMahon,et al.  Role of the Immune system in chronic pain , 2005, Nature Reviews Neuroscience.

[12]  Petros P Sfikakis,et al.  The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. , 2010, Current directions in autoimmunity.

[13]  J. Mika.  Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness. , 2008, Pharmacological reports : PR.

[14]  Kirk W. Johnson,et al.  Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats , 2007, Brain, Behavior, and Immunity.

[15]  D. Coyle,et al.  Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior , 1998, Glia.

[16]  Yimin Zhao,et al.  Hyperalgesia in response to traumatic occlusion and GFAP expression in rat parabranchial nucleus: modulation with fluorocitrate , 2007, Cell and Tissue Research.

[17]  J. Trosko,et al.  Endogenous and exogenous modulation of gap junctional intercellular communication: toxicological and pharmacological implications. , 1993, Life sciences.

[18]  S. Maier,et al.  Spinal Glia and Proinflammatory Cytokines Mediate Mirror-Image Neuropathic Pain in Rats , 2003, The Journal of Neuroscience.

[19]  S. Maier,et al.  Glia: novel counter-regulators of opioid analgesia , 2005, Trends in Neurosciences.

[20]  Mario Mellado,et al.  Ligand stabilization of CXCR4/δ‐opioid receptor heterodimers reveals a mechanism for immune response regulation , 2008, European journal of immunology.

[21]  K. Noguchi,et al.  Interleukin-18-Mediated Microglia/Astrocyte Interaction in the Spinal Cord Enhances Neuropathic Pain Processing after Nerve Injury , 2008, The Journal of Neuroscience.

[22]  B. Ziółkowska,et al.  Chronic morphine increases biosynthesis of nitric oxide synthase in the rat spinal cord , 1997, Neuroreport.

[23]  N. Mosaffa,et al.  Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain. , 2006, European journal of pharmacology.

[24]  K. Dorovini‐Zis,et al.  Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide , 2010, Journal of Neuroinflammation.

[25]  M. Korostyński,et al.  Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain. , 2009, European journal of pharmacology.

[26]  Kirk W. Johnson,et al.  Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain , 2006, Pain.

[27]  P. Blanco,et al.  Neuropathy resembling CIDP in patients receiving tumor necrosis factor-α blockers , 2005, Neurology.

[28]  L. Joosten,et al.  The human anti-IL-1β monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis , 2008, Arthritis research & therapy.

[29]  B. Przewłocka,et al.  Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain , 2010, Neuroscience.

[30]  H. Tozaki-Saitoh,et al.  JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats. , 2011, Brain : a journal of neurology.

[31]  Dong-Kug Choi,et al.  Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease , 2002, The Journal of Neuroscience.

[32]  Ji-Tian Xu,et al.  Peri-sciatic administration of recombinant rat TNF-α induces mechanical allodynia via upregulation of TNF-α in dorsal root ganglia and in spinal dorsal horn: The role of NF-kappa B pathway , 2007, Experimental Neurology.

[33]  O. Steward,et al.  Genetic influences on cellular reactions to spinal cord injury: Activation of macrophages/microglia and astrocytes is delayed in mice carrying a mutation (WldS) that causes delayed Wallerian degeneration , 1996, The Journal of comparative neurology.

[34]  W. Serednicki,et al.  Pentoxifylline does not affect nociception if administered postoperatively. , 2004, Polish journal of pharmacology.

[35]  Xiaohong Yuan,et al.  Effects of Glial Cell Line-Derived Neurotrophic Factor Intrathecal Injection on Spinal Dorsal Horn Glial Fibrillary Acidic Protein Expression in a Rat Model of Neuropathic Pain , 2012, The International journal of neuroscience.

[36]  F. Cunha,et al.  Analgesic effect of thalidomide on inflammatory pain. , 2000, European journal of pharmacology.

[37]  N. Bowery,et al.  Effect of interleukin-1 beta on the release of substance P from rat isolated spinal cord. , 1996, European journal of pharmacology.

[38]  Koji Okabe,et al.  Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo , 2004, Nature Medicine.

[39]  Min-Chi Ku,et al.  Reduced 2,4‐dinitro‐1‐fluorobenzene‐induced contact hypersensitivity response in IL‐15 receptor α‐deficient mice correlates with diminished CCL5/RANTES and CXCL10/IP‐10 expression , 2005, European journal of immunology.

[40]  F. Cunha,et al.  Antinociceptive Effects of Interleukin-4, -10, and -13 on the Writhing Response in Mice and Zymosan-Induced Knee Joint Incapacitation in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[41]  J. Deleo,et al.  Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain , 2001, Neuroscience.

[42]  W. Hickey,et al.  Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat , 1997, Journal of Neuroimmunology.

[43]  T. Marunouchi,et al.  Interleukin‐10 Inhibits Both Production of Cytokines and Expression of Cytokine Receptors in Microglia , 1999, Journal of neurochemistry.

[44]  J. Deleo,et al.  Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain , 2004, Neurochemistry International.

[45]  S. McMahon,et al.  Effects of Etanercept and Minocycline in a rat model of spinal cord injury , 2009, European journal of pain.

[46]  J. Willis,et al.  A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. , 2003, Gastroenterology.

[47]  M. Takigawa,et al.  Kunitz-type Protease Inhibitor Bikunin Disrupts Phorbol Ester-induced Oligomerization of CD44 Variant Isoforms Containing Epitope v9 and Subsequently Suppresses Expression of Urokinase-type Plasminogen Activator in Human Chondrosarcoma Cells* , 2002, The Journal of Biological Chemistry.

[48]  G. Reiser,et al.  Gap‐junction blocker carbenoxolone differentially enhances NMDA‐induced cell death in hippocampal neurons and astrocytes in co‐culture , 2007, Journal of neurochemistry.

[49]  S. Maier,et al.  Behavioral/systems/cognitive a Role for Proinflammatory Cytokines and Fractalkine in Analgesia, Tolerance, and Subsequent Pain Facilitation Induced by Chronic Intrathecal Morphine , 2022 .

[50]  Takeshi Kato,et al.  Effect of Memantine on the Levels of Neuropeptides and Microglial Cells in the Brain Regions of Rats with Neuropathic Pain , 2009, Journal of Molecular Neuroscience.

[51]  D. Furst.  Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis. , 2004, Clinical therapeutics.

[52]  K. Keay,et al.  Anatomically specific patterns of glial activation in the periaqueductal gray of the sub-population of rats showing pain and disability following chronic constriction injury of the sciatic nerve , 2010, Neuroscience.

[53]  L. Sorkin,et al.  Tumor Necrosis Factor-α Induces Mechanical Allodynia after Spinal Nerve Ligation by Activation of p38 MAPK in Primary Sensory Neurons , 2003, The Journal of Neuroscience.

[54]  T. Marunouchi,et al.  Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. , 1993, Journal of immunology.

[55]  T. Hökfelt,et al.  Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[56]  I. Decosterd,et al.  A Peptide c-Jun N-Terminal Kinase (JNK) Inhibitor Blocks Mechanical Allodynia after Spinal Nerve Ligation: Respective Roles of JNK Activation in Primary Sensory Neurons and Spinal Astrocytes for Neuropathic Pain Development and Maintenance , 2006, The Journal of Neuroscience.

[57]  S. McMahon,et al.  Role of spinal microglia in rat models of peripheral nerve injury and inflammation , 2007, European journal of pain.

[58]  J. Singh,et al.  ▼Tocilizumab for rheumatoid arthritis , 2009, Drug and Therapeutics Bulletin.

[59]  Clifford J. Woolf,et al.  Complement Induction in Spinal Cord Microglia Results in Anaphylatoxin C5a-Mediated Pain Hypersensitivity , 2007, The Journal of Neuroscience.

[60]  T. Sugimoto,et al.  Activation of microglia and p38 mitogen-activated protein kinase in the dorsal column nucleus contributes to tactile allodynia following peripheral nerve injury , 2008, Neuroscience.

[61]  P. Mantyh,et al.  Constitutive Spinal Cyclooxygenase-2 Participates in the Initiation of Tissue Injury-Induced Hyperalgesia , 2004, The Journal of Neuroscience.

[62]  D. Price,et al.  Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. Mattsson,et al.  Complement and clusterin in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat , 1995, Neuroscience.

[64]  P. Gasque,et al.  Expression of complement in the brain: role in health and disease. , 1996, Immunology today.

[65]  L. Lachman,et al.  Interleukin 1 of the central nervous system is produced by ameboid microglia , 1986, The Journal of experimental medicine.

[66]  R. Jancalek,et al.  Open Access Research , 2022 .

[67]  S. Abramson,et al.  A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[68]  M. Kress,et al.  IL‐1J potentiates heat‐activated currents in rat sensory neurons: involvement of IL‐1RI, tyrosine kinase, and protein kinase C , 2002 .

[69]  J. Deleo,et al.  Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. , 2001, The Journal of pharmacology and experimental therapeutics.

[70]  S. Aou,et al.  Intracerebroventricular injection of interleukin-1β induces hyperalgesia in rats , 1993, Brain Research.

[71]  Eija Kalso,et al.  Opioids in chronic non-cancer pain: systematic review of efficacy and safety , 2004, Pain.

[72]  S. Maier,et al.  Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. , 2003, Advances in experimental medicine and biology.

[73]  E. Weihe,et al.  Molecular anatomy of the neuro-immune connection. , 1991, The International journal of neuroscience.

[74]  R. Przewłocki,et al.  Opioids in neuropathic pain. , 2005, Current pharmaceutical design.

[75]  Steven A. Johnson,et al.  Expression of complement C1gB and C4 mRNAs during rat brain development , 1994 .

[76]  L. Duan,et al.  The lumbar spinal cord glial cells actively modulate subcutaneous formalin induced hyperalgesia in the rat , 2006, Neuroscience Research.

[77]  T. Waldmann,et al.  IL-15 induces the expression of chemokines and their receptors in T lymphocytes. , 1999, Journal of immunology.

[78]  S. Maier,et al.  Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation , 2005, Pain.

[79]  C. J. Garrison,et al.  Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury , 1991, Brain Research.

[80]  M. Kress,et al.  Involvement of the Proinflammatory Cytokines Tumor Necrosis Factor-α, IL-1β, and IL-6 But Not IL-8 in the Development of Heat Hyperalgesia: Effects on Heat-Evoked Calcitonin Gene-Related Peptide Release from Rat Skin , 2000, The Journal of Neuroscience.

[81]  John Grist,et al.  CCL2 is a key mediator of microglia activation in neuropathic pain states , 2009, European journal of pain.

[82]  R. Przewłocki,et al.  Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. , 1993, Life sciences.

[83]  S. Maier,et al.  Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia , 2008, Brain, Behavior, and Immunity.

[84]  R. Przewłocki,et al.  The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients. , 2000, Life sciences.

[85]  K. Yin,et al.  Imiquimod attenuates airway inflammation and decreases the expression of thymus and activation regulated chemokine in allergic asthmatic mice. , 2006, Chinese medical journal.

[86]  A. Alshekhlee,et al.  Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor‐α antagonists , 2010, Muscle & nerve.

[87]  C. Woolf,et al.  p38 Mitogen-Activated Protein Kinase Is Activated after a Spinal Nerve Ligation in Spinal Cord Microglia and Dorsal Root Ganglion Neurons and Contributes to the Generation of Neuropathic Pain , 2003, The Journal of Neuroscience.

[88]  J. Deleo,et al.  Acute peripheral inflammation induces moderate glial activation and spinal IL-1β expression that correlates with pain behavior in the rat 1 Published on the World Wide Web on 17 March 1999. 1 , 1999, Brain Research.

[89]  P. Dougherty,et al.  Spinal injection of IL-2 or IL-15 alters mechanical and thermal withdrawal thresholds in rats , 2008, Neuroscience Letters.

[90]  T. J. Nickola,et al.  Brain-derived TNFα mediates neuropathic pain , 1999, Brain Research.

[91]  S. Chakravarti,et al.  Differential Expression of Inflammatory and Fibrogenic Genes and Their Regulation by NF-κB Inhibition in a Mouse Model of Chronic Colitis1 , 2007, The Journal of Immunology.

[92]  B. Fiebich,et al.  Minocycline, a Tetracycline Derivative, Is Neuroprotective against Excitotoxicity by Inhibiting Activation and Proliferation of Microglia , 2001, The Journal of Neuroscience.

[93]  E. Boddeke,et al.  Involvement of chemokines in pain. , 2001, European journal of pharmacology.

[94]  L. O’Neill,et al.  Targeting signal transduction as a strategy to treat inflammatory diseases , 2006, Nature Reviews Drug Discovery.

[95]  L. Notarangelo,et al.  Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes , 1997 .

[96]  S. Waxman,et al.  Activated Microglia Contribute to the Maintenance of Chronic Pain after Spinal Cord Injury , 2006, The Journal of Neuroscience.

[97]  C. Borel,et al.  Preincisional Intravenous Pentoxifylline Attenuating Perioperative Cytokine Response, Reducing Morphine Consumption, and Improving Recovery of Bowel Function in Patients Undergoing Colorectal Cancer Surgery , 2004, Anesthesia and analgesia.

[98]  Yanzhang Li,et al.  The Effects of Local Pentoxifylline and Propentofylline Treatment on Formalin-Induced Pain and Tumor Necrosis Factor-α Messenger RNA Levels in the Inflamed Tissue of the Rat Paw , 2004, Anesthesia and analgesia.

[99]  J. Deleo,et al.  Complete Freunds adjuvant‐induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS , 2004, The European journal of neuroscience.

[100]  J. Mallet,et al.  Lentiviral-mediated Targeted NF-κB Blockade in Dorsal Spinal Cord Glia Attenuates Sciatic Nerve Injury-induced Neuropathic Pain in the Rat. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[101]  S. Caccia,et al.  Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[102]  J. Wordliczek,et al.  Radiofrequency denervation with or without addition of pentoxifylline or methylprednisolone for chronic lumbar zygapophysial joint pain. , 2005, Pharmacological reports : PR.

[103]  S. Bevan,et al.  Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.

[104]  N. Rothwell,et al.  Cytokines and the nervous system I: expression and recognition , 1995, Trends in Neurosciences.

[105]  S. Kishida,et al.  Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica , 2012, European Spine Journal.

[106]  R. Knobler,et al.  Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells. , 1994, Immunology.

[107]  J. Glorioso,et al.  HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain , 2006, Molecular pain.

[108]  S. Maier,et al.  GLIA: A novel drug discovery target for clinical pain , 2003, Nature Reviews Drug Discovery.

[109]  S. Maier,et al.  Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120 , 2007, Brain, Behavior, and Immunity.

[110]  C. Heusser,et al.  Release and Inactivation of Interleukin‐4 by Mast Cells a , 1994, Annals of the New York Academy of Sciences.

[111]  C. Brosnan,et al.  Modulation of Interleukin-1β and Tumor Necrosis Factor α Signaling by P2 Purinergic Receptors in Human Fetal Astrocytes , 2000, The Journal of Neuroscience.

[112]  R. Ying,et al.  The Antinociceptive Efficacy of HWTX-I Epidurally Administered in Rheumatoid Arthritis Rats , 2011, International Journal of Sports Medicine.

[113]  T. Kurotani,et al.  Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia , 2004, Neuropharmacology.

[114]  B. Przewłocka,et al.  Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. , 2007, European journal of pharmacology.

[115]  R Wagner,et al.  Tumour necrosis factor-α induces ectopic activity in nociceptive primary afferent fibres , 1997, Neuroscience.

[116]  R. Ji,et al.  Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine , 2007, Brain, Behavior, and Immunity.

[117]  A. Suzumura,et al.  Ibudilast suppresses TNFα production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS , 1999, Brain Research.

[118]  Mark R Hutchinson,et al.  The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. , 2009, Trends in pharmacological sciences.

[119]  J. Cidlowski,et al.  Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors , 1995, Molecular and cellular biology.

[120]  T. Engber,et al.  Multiple actions of systemic artemin in experimental neuropathy , 2003, Nature Medicine.

[121]  T. Sun,et al.  Alleviation of neuropathic pain by intrathecal injection of antisense oligonucleotides to p65 subunit of NF-kappaB. , 2006, British journal of anaesthesia.

[122]  F. Aloisi.  Immune function of microglia , 2001, Glia.

[123]  Joseph A. DiDonato,et al.  Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.

[124]  J. Deleo,et al.  Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines , 2003, Pain.

[125]  L. Gordon,et al.  Etanercept associated optic neuropathy , 2007, Clinical & experimental ophthalmology.

[126]  E. Zhang,et al.  Dynorphin Promotes Abnormal Pain and Spinal Opioid Antinociceptive Tolerance , 2000, The Journal of Neuroscience.

[127]  M. Korostyński,et al.  Comparison of gene expression profiles in neuropathic and inflammatory pain. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[128]  C. Sommer,et al.  Etanercept reduces hyperalgesia in experimental painful neuropathy , 2001, Journal of the peripheral nervous system : JPNS.

[129]  Maria Fitzgerald,et al.  T-Cell Infiltration and Signaling in the Adult Dorsal Spinal Cord Is a Major Contributor to Neuropathic Pain-Like Hypersensitivity , 2009, The Journal of Neuroscience.

[130]  Dante R Chialvo,et al.  Inflammatory and neuropathic pain animals exhibit distinct responses to innocuous thermal and motoric challenges , 2006, Molecular pain.

[131]  R. Ji,et al.  Targeting astrocyte signaling for chronic pain , 2010, Neurotherapeutics.

[132]  S. Maier,et al.  Peri-sciatic proinflammatory cytokines, reactive oxygen species, and complement induce mirror-image neuropathic pain in rats , 2004, Pain.

[133]  Huimin Wang,et al.  PPARγ agonist pioglitazone inhibits microglia inflammation by blocking p38 mitogen-activated protein kinase signaling pathways , 2010, Inflammation Research.

[134]  Yi Dai,et al.  Activation of Src-Family Kinases in Spinal Microglia Contributes to Mechanical Hypersensitivity after Nerve Injury , 2006, The Journal of Neuroscience.

[135]  M. Korostyński,et al.  Interleukin-1alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model , 2008, PAIN.

[136]  B. Przewłocka,et al.  The role of nociceptin and dynorphin in chronic pain: Implications of neuro–glial interaction , 2011, Neuropeptides.

[137]  D. Gruol,et al.  Physiological and pathological roles of interleukin-6 in the central nervous system , 1997, Molecular Neurobiology.

[138]  K. Prickett,et al.  The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. , 1987, The Journal of biological chemistry.

[139]  R. Treede,et al.  Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update SUPPLEMENT ARTICLE , 2010 .

[140]  R. Deumens,et al.  Inverse relation between intensity of GFAP expression in the substantia gelatinosa and degree of chronic mechanical allodynia , 2009, Neuroscience Letters.

[141]  H. Ueno,et al.  Activation of dorsal horn microglia contributes to diabetes‐induced tactile allodynia via extracellular signal‐regulated protein kinase signaling , 2008, Glia.

[142]  F. D’Acquisto,et al.  Glatiramer acetate attenuates neuropathic allodynia through modulation of adaptive immune cells , 2011, Journal of Neuroimmunology.

[143]  M. Haber,et al.  Cooperative Astrocyte and Dendritic Spine Dynamics at Hippocampal Excitatory Synapses , 2006, The Journal of Neuroscience.

[144]  W. Cruce,et al.  Neuropathic pain in aged rats: behavioral responses and astrocytic activation , 2001, Experimental Brain Research.

[145]  K. Osuka,et al.  Activation of JAK/STAT signalling in neurons following spinal cord injury in mice , 2006, Journal of neurochemistry.

[146]  W. Guo,et al.  Supraspinal Glial–Neuronal Interactions Contribute to Descending Pain Facilitation , 2008, The Journal of Neuroscience.

[147]  S. Jander,et al.  The role of microglia and macrophages in the pathophysiology of the CNS , 1999, Progress in Neurobiology.

[148]  Stephen B. McMahon,et al.  Immune and glial cell factors as pain mediators and modulators , 2005, Experimental Neurology.

[149]  G. Kreutzberg.  Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[150]  P. Gebicke-haerter,et al.  Release of ATP from cultured rat astrocytes elicited by glutamate receptor activation , 1997, Neuroscience.

[151]  S. Genevay,et al.  Efficacy of etanercept in the treatment of acute, severe sciatica: a pilot study , 2004, Annals of the rheumatic diseases.

[152]  J. Alferink,et al.  Interferon-γ Is a Critical Modulator of CB2 Cannabinoid Receptor Signaling during Neuropathic Pain , 2008, The Journal of Neuroscience.

[153]  R. Yezierski,et al.  The role of neuroinflammation and neuroimmune activation in persistent pain , 2001, Pain.

[154]  T. Kohnen,et al.  Anterior Optic Neuropathy Associated with Adalimumab , 2008, Ophthalmologica.

[155]  I. Decosterd,et al.  Nerve Conduction Blockade in the Sciatic Nerve Prevents but Does Not Reverse the Activation of p38 Mitogen-activated Protein Kinase in Spinal Microglia in the Rat Spared Nerve Injury Model , 2007, Anesthesiology.

[156]  J. Deleo,et al.  Attenuation of Morphine Tolerance, Withdrawal-Induced Hyperalgesia, and Associated Spinal Inflammatory Immune Responses by Propentofylline in Rats , 2004, Neuropsychopharmacology.

[157]  R. Paxton,et al.  IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. , 1995, Journal of immunology.

[158]  C. Woolf,et al.  Neuropathic pain: aetiology, symptoms, mechanisms, and management , 1999, The Lancet.

[159]  Xin-jia Wang,et al.  Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury , 2005, Acta Pharmacologica Sinica.

[160]  Paresh D Patel,et al.  Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons , 2004, The Journal of Neuroscience.

[161]  P. Knuefermann,et al.  The toll‐like receptor 4‐antagonist eritoran reduces murine cardiac hypertrophy , 2011, European journal of heart failure.

[162]  S. Duan,et al.  P2X7 Receptor-Mediated Release of Excitatory Amino Acids from Astrocytes , 2003, The Journal of Neuroscience.

[163]  A. Malhotra,et al.  Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[164]  B. Przewłocka,et al.  Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain , 2008, PAIN.

[165]  S. Kohsaka,et al.  Microglia: activation and their significance in the central nervous system. , 2001, Journal of biochemistry.

[166]  Yuan Zhang,et al.  Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. , 1999, Science.

[167]  F. Granucci,et al.  Glial TLR4 receptor as new target to treat neuropathic pain: Efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice , 2008, Glia.

[168]  B. Przewłocka,et al.  Glial inhibitors influence the mRNA and protein levels of mGlu2/3, 5 and 7 receptors and potentiate the analgesic effects of their ligands in a mouse model of neuropathic pain , 2009, PAIN®.

[169]  C. Woolf,et al.  ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model , 2005, Pain.

[170]  M. Adler,et al.  Viewing chemokines as a third major system of communication in the brain , 2005, The AAPS Journal.

[171]  B. Przewłocka,et al.  Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice , 2009, Brain, Behavior, and Immunity.

[172]  J. Mao,et al.  Chronic Morphine Induces Downregulation of Spinal Glutamate Transporters: Implications in Morphine Tolerance and Abnormal Pain Sensitivity , 2022 .

[173]  Y. Mizushima,et al.  Effect of ibudilast: a novel antiasthmatic agent, on airway hypersensitivity in bronchial asthma. , 1992, The Journal of asthma : official journal of the Association for the Care of Asthma.

[174]  T. Yaksh,et al.  Spinal synthesis and release of prostanoids after peripheral injury and inflammation. , 1999, Advances in experimental medicine and biology.

[175]  A. Dickenson,et al.  Spinal interleukin-6 (IL-6) inhibits nociceptive transmission following neuropathy , 2003, Brain Research.

[176]  G. Geisslinger,et al.  Different COX-independent effects of the COX-2 inhibitors etoricoxib and lumiracoxib. , 2006, Biochemical and biophysical research communications.

[177]  R. Myers,et al.  Immediate anti‐tumor necrosis factor‐α (etanercept) therapy enhances axonal regeneration after sciatic nerve crush , 2010, Journal of neuroscience research.

[178]  B. Winkelstein,et al.  Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment , 2001, The Journal of comparative neurology.

[179]  R. Campbell,et al.  Structure, organization, and regulation of the complement genes. , 1988, Annual review of immunology.

[180]  A. Serrano,et al.  Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain , 2010, Molecular pain.

[181]  J. Pouget,et al.  Acute motor and sensory axonal neuropathy and concomitant encephalopathy during tumor necrosis factor-alpha antagonist therapy , 2010, Journal of the Neurological Sciences.

[182]  M. Tominaga,et al.  Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins , 2005, Molecular pain.

[183]  M. Fitzgerald,et al.  Age-related changes in the spinal cord microglial and astrocytic response profile to nerve injury , 2007, Brain, Behavior, and Immunity.

[184]  M. Svensson,et al.  A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat , 1993, Experimental Brain Research.

[185]  S. Brull,et al.  Acute topical application of tumor necrosis factor alpha evokes protein kinase A-dependent responses in rat sensory neurons. , 2002, Journal of neurophysiology.

[186]  p38 MAPK, microglial signaling, and neuropathic pain , 2007, Molecular pain.

[187]  Xiao-Li Li,et al.  Interleukin-1β of Red nucleus involved in the development of allodynia in spared nerve injury rats , 2008, Experimental Brain Research.

[188]  R. Rush,et al.  Satellite‐cell‐derived nerve growth factor and neurotrophin‐3 are involved in noradrenergic sprouting in the dorsal root ganglia following peripheral nerve injury in the rat , 1999, The European journal of neuroscience.

[189]  M. Isobe,et al.  Ibudilast: a non-selective PDE inhibitor with multiple actions on blood cells and the vascular wall. , 2006, Cardiovascular drug reviews.

[190]  S. Maeda,et al.  Intrathecal administration of ATP produces long-lasting allodynia in rats: Differential mechanisms in the phase of the induction and maintenance , 2007, Neuroscience.

[191]  S. Maier,et al.  Intrathecal HIV-1 Envelope Glycoprotein gp120 Induces Enhanced Pain States Mediated by Spinal Cord Proinflammatory Cytokines , 2001, The Journal of Neuroscience.

[192]  Rena Li,et al.  Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain , 1997, Brain Research.

[193]  E. Frank,et al.  Persistent restoration of sensory function by immediate or delayed systemic artemin after dorsal root injury , 2008, Nature Neuroscience.

[194]  V. Tawfik,et al.  Neuroimmune Activation and Neuroinflammation in Chronic Pain and Opioid Tolerance/Hyperalgesia , 2004, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[195]  M. Nedergaard,et al.  Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. , 1994, Science.

[196]  R. Lundblad,et al.  Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intra-abdominal sepsis in rats. , 1995, Shock.

[197]  H. Lee,et al.  Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model , 2004, Neuroreport.

[198]  R. Jancalek,et al.  Intra- and Extraneuronal Changes of Immunofluorescence Staining for TNF- and TNFR1 in the Dorsal Root Ganglia of Rat Peripheral Neuropathic Pain Models , 2006, Cellular and Molecular Neurobiology.

[199]  Yu-Qiu Zhang,et al.  New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis , 2007, Pain.

[200]  C. Sommer,et al.  Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-α, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin , 2000, PAIN.

[201]  J. Mika.  The opioid systems and the role of glial cells in the effects of opioids , 2008 .

[202]  S. Grösch,et al.  Opposite Effects of Rofecoxib on Nuclear Factor-κB and Activating Protein-1 Activation , 2003, Journal of Pharmacology and Experimental Therapeutics.

[203]  N. Rothwell,et al.  Potential mechanisms of interleukin-1 involvement in cerebral ischaemia , 1999, Journal of Neuroimmunology.

[204]  M. Hutchinson,et al.  Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease , 2009, Expert opinion on pharmacotherapy.

[205]  D. Gomez-Nicola,et al.  Role of IL‐15 in spinal cord and sciatic nerve after chronic constriction injury: regulation of macrophage and T‐cell infiltration , 2008, Journal of neurochemistry.

[206]  A. Beitz,et al.  Intrathecal injection of carbenoxolone, a gap junction decoupler, attenuates the induction of below-level neuropathic pain after spinal cord injury in rats , 2010, Experimental Neurology.

[207]  J. Grondin,et al.  Induction of interleukin-6 in axotomized sensory neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[208]  P. VandeVord,et al.  Modulation of neuropathic pain by a glial-derived factor. , 2009, Pain medicine.

[209]  Linda R Watkins,et al.  Spinal cord glia: new players in pain , 2001, Pain.

[210]  S. Ghosh,et al.  Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation. , 2005, Arthritis and rheumatism.

[211]  H. Kimura,et al.  Inactivation of TNF-α ameliorates diabetic neuropathy in mice. , 2011, American journal of physiology. Endocrinology and metabolism.

[212]  F. Cunha,et al.  Cytokine‐mediated inflammatory hyperalgesia limited by interleukin‐4 , 1995, British journal of pharmacology.

[213]  David A. Willoughby,et al.  Complement C1qB and C4 mRNAs responses to lesioning in rat brain , 1992, Experimental Neurology.

[214]  G. Burmester,et al.  Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA) , 2010, Annals of the rheumatic diseases.

[215]  S. Koizumi,et al.  Activation of p38 mitogen‐activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury , 2004, Glia.

[216]  Guei-Sheung Liu,et al.  Glial cell line-derived neurotrophic factor gene transfer exerts protective effect on axons in sciatic nerve following constriction-induced peripheral nerve injury. , 2011, Human gene therapy.

[217]  Gila Moalem-Taylor,et al.  The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines , 2010, Journal of Neuroimmunology.

[218]  F. Hucho,et al.  Analysis of the dorsal spinal cord synaptic architecture by combined proteome analysis and in situ hybridization. , 2005, Journal of proteome research.

[219]  F. Liew,et al.  Antigen-induced inflammatory mechanical hypernociception in mice is mediated by IL-18 , 2007, Brain, Behavior, and Immunity.

[220]  T. Morgan,et al.  Kainic Acid and Decorticating Lesions Stimulate the Synthesis of C1q Protein in Adult Rat Brain , 1997, Journal of neurochemistry.

[221]  S. Oliet,et al.  Neuron-glia interactions in the rat supraoptic nucleus. , 2008, Progress in brain research.

[222]  J. de Vellis,et al.  Tumor necrosis factor‐α regulation of the Id gene family in astrocytes and microglia during CNS inflammatory injury , 1999, Glia.

[223]  A. Mauborgne,et al.  JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat , 2008, Journal of neurochemistry.

[224]  Juliette van Steenwinckel,et al.  CCL2 Released from Neuronal Synaptic Vesicles in the Spinal Cord Is a Major Mediator of Local Inflammation and Pain after Peripheral Nerve Injury , 2011, The Journal of Neuroscience.

[225]  L. Lao,et al.  Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia , 2005, Pain.

[226]  Ping-Heng Tan,et al.  Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain , 2008, Nature Medicine.

[227]  Hosung Jung,et al.  Chemokines and the pathophysiology of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.

[228]  J. Deleo,et al.  The Effect of Site and Type of Nerve Injury on Spinal Glial Activation and Neuropathic Pain Behavior , 1999, Experimental Neurology.

[229]  J. Lamb,et al.  TH2 cells in allergic inflammation: a target of immunotherapy , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[230]  S. Grösch,et al.  Inhibition of NF‐ κ B and AP‐1 activation by R‐ and S‐flurbiprofen 1 2 , 2001 .

[231]  R. Myers,et al.  Peripheral Nerve Pathology Following Sciatic Cryoneurolysis: Relationship to Neuropathic Behaviors in the Rat , 1995, Experimental Neurology.

[232]  J. Relton,et al.  Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat , 1992, Brain Research Bulletin.